Konecny GE - Search Results

1

Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.

von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA, Gerber B, Eiermann W, Hilfrich J, Huober J, Jackisch C, Kaufmann M, Konecny GE, Denkert C, Nekljudova V, Mehta K, Loibl S. von Minckwitz G, et al. Among authors: konecny ge. J Clin Oncol. 2012 May 20;30(15):1796-804. doi: 10.1200/JCO.2011.38.8595. Epub 2012 Apr 16. J Clin Oncol. 2012. PMID: 22508812

2

[Use of G-CSF in dose-intensified chemotherapy of breast cancer with FEC (500/75/500 mg/m2 KO) in the adjuvant and metastatic situation].

Konecny G, Nestle-Krämling C, Untch M. Konecny G, et al. Gynakol Geburtshilfliche Rundsch. 1993;33 Suppl 1:301-2. doi: 10.1159/000272274. Gynakol Geburtshilfliche Rundsch. 1993. PMID: 7509677 German. No abstract available.

3

Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.

Luck HJ, Thomssen C, duBois A, Lisboa BW, Untch M, Kuhnle H, Konecny G, Janicke F, Meerpohl HG, Lindner C, Hecker D, Diergarten K. Luck HJ, et al. Semin Oncol. 1996 Feb;23(1 Suppl 1):33-6. Semin Oncol. 1996. PMID: 8629034 Clinical Trial.

4

[New drugs in therapy of breast carcinoma: current status and outlook].

Konecny G, Untch M, Hepp H. Konecny G, et al. Gynakol Geburtshilfliche Rundsch. 1997;37(2):54-61. doi: 10.1159/000272832. Gynakol Geburtshilfliche Rundsch. 1997. PMID: 9445630 Review. German.

5

Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.

Konecny G, Crohns C, Pegram M, Felber M, Lude S, Kurbacher C, Cree IA, Hepp H, Untch M. Konecny G, et al. Gynecol Oncol. 2000 May;77(2):258-63. doi: 10.1006/gyno.2000.5728. Gynecol Oncol. 2000. PMID: 10785475

6

[Retrospective analysis of dose intensity of epirubicin in breast cancer].

Konecny G, Frank M, Kahlert S, Untch M, Hepp H. Konecny G, et al. Gynakol Geburtshilfliche Rundsch. 2000;40(3-4):145-52. doi: 10.1159/000053017. Gynakol Geburtshilfliche Rundsch. 2000. PMID: 11326159 German.

7

Dose-dense and sequential strategies in adjuvant breast cancer therapy.

Untch M, Von Koch F, Crohns C, Sobotta K, Kahlert S, Konecny G, Hepp H. Untch M, et al. Oncology (Williston Park). 2001 May;15(5 Suppl 7):14-20. Oncology (Williston Park). 2001. PMID: 11396359 Free article. Review.

8

Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer.

Konecny G, Untch M, Pihan A, Kimmig R, Gropp M, Stieber P, Hepp H, Slamon D, Pegram M. Konecny G, et al. Clin Cancer Res. 2001 Jun;7(6):1743-9. Clin Cancer Res. 2001. PMID: 11410515

9

Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.

Konecny G, Untch M, Arboleda J, Wilson C, Kahlert S, Boettcher B, Felber M, Beryt M, Lude S, Hepp H, Slamon D, Pegram M. Konecny G, et al. Clin Cancer Res. 2001 Aug;7(8):2448-57. Clin Cancer Res. 2001. PMID: 11489825

10

HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer.

Konecny G, Fritz M, Untch M, Lebeau A, Felber M, Lude S, Beryt M, Hepp H, Slamon D, Pegram M. Konecny G, et al. Breast Cancer Res Treat. 2001 Sep;69(1):53-63. doi: 10.1023/a:1012226006395. Breast Cancer Res Treat. 2001. PMID: 11759828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters